MEDPLUS NSE filing

Medplus Health Services Holds 20th AGM on Aug 17, 2026

The RealCase readLow impact Neutral

MedPlus Health Services Limited conducted its 20th AGM on August 17, 2026. The meeting included the adoption of audited standalone and consolidated financial statements for FY2026. Key decisions involved re-appointing existing directors and appointing new independent directors. Voting results will be announced post-submission to exchanges.

Why it matters

The announcement details the proceedings of a routine Annual General Meeting and does not introduce any new material information that would significantly impact the company's operations or stock price.

The market read

The announcement is a routine update regarding the company's Annual General Meeting proceedings and does not contain any new financial information or strategic decisions that would significantly impact the sentiment.

MedPlus Health Services Limited held its 20th Annual General Meeting (AGM) on Monday, August 17, 2026, commencing at 3:30 p.m. IST and concluding at 4:47 p.m. IST, conducted through Video Conferencing (VC) / Other Audio Visual Means (OAVM).

The meeting, deemed to be held at the Company's Registered Office in Hyderabad, was attended by 134 members. The Directors present included Mr. Gangadi Madhukar Reddy (Chairman - Managing Director and CEO), Dr. Cherukupalli Bhaskar Reddy (Whole Time Director), and several Non-Executive Independent Directors. Key personnel in attendance included the Chief Financial Officer, Company Secretary & Compliance Officer, Statutory Auditors from B S R and Co, and the Secretarial Auditor from R & A Associates.

The Chairman delivered his speech, and it was noted that the Statutory Auditors and Secretarial Auditors expressed unqualified opinions for the Financial Year 2025-2026, with no adverse comments on the financial statements. The Audited Standalone & Consolidated Financial Statements for the Financial Year ended March 31, 2026, along with the Reports of the Board of Directors and Auditors, were taken as read.

Key business transacted included the adoption of the Audited Standalone & Consolidated Financial Statements, the re-appointment of Dr. Cherukupalli Bhaskar Reddy as a Director retiring by rotation, the appointment of Mr. Mohan Krishna Reddy and Mr. Ajit Pandurang Rangnekar as Independent Directors, the re-appointment of Mr. Gangadi Madhukar Reddy as Managing Director & CEO, and the ratification of remuneration for the Cost Auditors, M/s. M P R & Associates.

Members were provided the facility for remote e-voting from August 14, 2026, to August 16, 2026, and an opportunity for e-voting at the AGM through Insta Poll. The consolidated results of the voting, along with the Scrutinizer’s Report, will be submitted to the stock exchanges and uploaded on the Company’s website and KFin Technologies Limited's website within the prescribed timelines.

Filing to action

What to do with a filing like this

Medplus Health Services Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Medplus Health Services Limited. Read the original for the full detail.

View original filing